Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023)
Ginkgo Bioworks Holdings (DNA) reported Finished Goods of $4.4 million for Q2 2023, down 41.06% on a YoY basis from $7.5 million in Q2 2022, and down 16.26% quarter-over-quarter from $5.3 million in Q1 2023.
Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings has reported Finished Goods for 4 years, with the latest figure at $4.4 million in Q2 2023.
- For the quarter ending Q2 2023, Finished Goods fell 41.06% year-over-year to $4.4 million; the trailing twelve-month figure through Jun 2023 stood at $4.4 million (down 41.06% YoY), and the FY2022 full-year result was $6.6 million, up 100.86% from the prior year.
- Finished Goods for Q2 2023 stood at $4.4 million, down from $5.3 million in the prior quarter.
- The five-year high for Finished Goods was $8.0 million in Q1 2022, with the low at $2.5 million in Q3 2021.
- Historically, Finished Goods has averaged $5.1 million across 4 years, with a median of $5.3 million in 2023.
- Annual changes were most pronounced in 2022 — Finished Goods soared 120.66% — and 2023, when it tumbled 41.06%.
- Ginkgo Bioworks Holdings' Finished Goods stood at $2.8 million in 2020, then gained by 18.43% to $3.3 million in 2021, then soared by 100.86% to $6.6 million in 2022, then tumbled by 32.35% to $4.4 million in 2023.
- The last three Finished Goods figures came in at $4.4 million (Q2 2023), $5.3 million (Q1 2023), and $6.6 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.44 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | 5.59 Mn |
| Jun 30, 2022 | 7.52 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Dec 31, 2020 | 2.76 Mn |